Literature DB >> 19410301

Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica.

T Tani1, K Sakimura, M Tsujita, T Nakada, M Tanaka, M Nishizawa, K Tanaka.   

Abstract

OBJECTIVE: Anti-aquaporin 4 antibodies (AQP4-Ab) are specifically detected in patients with neuromyelitis optica. To investigate the role of AQP4-Ab, we examined the antibody binding epitope using human and mouse mutant AQP4.
METHODS: We constructed human and mouse amino acid substitution AQP4 mutants and compared the reactivity with wild-form of human, mouse and rat AQP4.
RESULTS: The decreased intensity of AQP4-Ab staining with mouse AQP4 was recovered to that of human AQP4 with the mouse mutant A228E for 9 of the 10 sera.
CONCLUSIONS: The third extracellular loop of AQP4 is considered to be the major epitope for AQP4-Ab in NMO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410301     DOI: 10.1016/j.jneuroim.2009.04.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Homology between Klebsiella pneumoniae and human aquaporin-4: no evidence for cross-reactivity in neuromyelitis optica. A study on 114 patients.

Authors:  S Jarius; K P Wandinger; S Platzer; B Wildemann
Journal:  J Neurol       Date:  2010-12-02       Impact factor: 4.849

2.  Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.

Authors:  Francesco Pisani; Mauro Mastrototaro; Andrea Rossi; Grazia Paola Nicchia; Carla Tortorella; Maddalena Ruggieri; Maria Trojano; Antonio Frigeri; Maria Svelto
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

Review 3.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

4.  Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.

Authors:  Raffaele Iorio; James P Fryer; Shannon R Hinson; Petra Fallier-Becker; Hartwig Wolburg; Sean J Pittock; Vanda A Lennon
Journal:  J Autoimmun       Date:  2012-08-18       Impact factor: 7.094

5.  Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.

Authors:  Patricia A Nelson; Mojgan Khodadoust; Thomas Prodhomme; Collin Spencer; Juan Carlos Patarroyo; Michel Varrin-Doyer; Joseph D Ho; Robert M Stroud; Scott S Zamvil
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 6.  Aquaporin water channels in the nervous system.

Authors:  Marios C Papadopoulos; Alan S Verkman
Journal:  Nat Rev Neurosci       Date:  2013-03-13       Impact factor: 34.870

7.  Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica.

Authors:  Zhihua Ren; Yan Wang; Tao Duan; Jilpa Patel; Thomas Liggett; Eileah Loda; Sarang Brahma; Rajendra Goswami; Carrie Grouse; Richard Byrne; Dusan Stefoski; Adil Javed; Stephen D Miller; Roumen Balabanov
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

8.  Aquaporin 4 molecular mimicry and implications for neuromyelitis optica.

Authors:  Radhika A Vaishnav; Ruolan Liu; Joab Chapman; Andrew M Roberts; Hong Ye; Jovan D Rebolledo-Mendez; Takeshi Tabira; Alicia H Fitzpatrick; Anat Achiron; Mark P Running; Robert P Friedland
Journal:  J Neuroimmunol       Date:  2013-05-09       Impact factor: 3.478

9.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

Review 10.  Molecular pathogenesis of neuromyelitis optica.

Authors:  Wajih Bukhari; Michael H Barnett; Kerri Prain; Simon A Broadley
Journal:  Int J Mol Sci       Date:  2012-10-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.